Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. - Wikidata - wikimedia - TriplyDB

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

http://www.wikidata.org/entity/Q34304330

about

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with hum In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS.First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry.Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18.In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.Oral fluid drug analysis in the age of new psychoactive substances.Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse.Analysis of AM-2201 and metabolites in a drugs and driving case.Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry.In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry.

P2860

Q28540537-2EA1CC0D-1D8D-4C02-B6C8-4AE80F4713E0 Q30244676-397598B0-24BC-4F37-8610-16FBF097B617 Q33162567-7EEBFDFB-ABC8-4517-B171-CB05A23EBD2F Q33908169-298E2B1A-0B0B-46C2-AA54-BD0ACA8CAE0D Q34156299-FD9A6283-25A2-44D8-8BFE-D8C4BD070506 Q34419089-CA660732-569E-431E-B375-1FB7838579A8 Q34464722-6E392502-C926-497C-8363-1B10F303AF52 Q34493135-75996614-0418-474D-90FE-65B2A923F2DB Q34501432-AC58E4C8-93C7-40B5-B6C3-229E983FA5A1 Q34514221-C90105C2-9579-42E7-83B1-BE2A3B1F6FAC Q34553148-18D9CE23-F07C-4DDE-8F6B-F79CF56391AA Q34607414-832DD9DD-0292-4A1A-A3E3-771778977DA5 Q35187100-5172673C-CC42-4A28-BC6A-61540CEE7FC0 Q35254099-B34EF092-ED5F-40EF-BD83-4780D4A101D5 Q35748441-324A9E37-FE1A-4681-BF27-C9F8637AF05E Q35956991-04B090E7-3F2D-4E48-AD21-B7CCF88013A3 Q35957128-3C6B9F8C-7BBD-450B-B923-F5DD349210DB Q36653901-FEB5A3AF-70F8-4C27-942A-262565DCB0F8 Q36950560-96BC662B-DF17-4941-B906-7387BA603DAD Q37207836-52703953-2333-4639-A3E5-7C7C42607301 Q37397048-AE7B28A4-4F69-4799-A15C-3F14C6DAC437 Q38411456-49151DE5-7229-437D-BB52-F5B7553F6920 Q38611708-27C0A81F-2320-4AD7-A53E-95621D56F690 Q38616637-215A97D5-C6F1-402B-AEBA-F5D7814AD163 Q38768825-30833DC4-D8EF-4C65-8C77-FF42A70EE9C6 Q39052265-8276F716-D00E-4247-8B98-5796487A2EBD Q42751412-5F4C4DBC-F7E3-4084-9004-8C9067EE2903 Q43641739-23916F0B-1C53-4FEE-A92C-1273B617726A Q45066806-3988CD61-0AD5-411B-A8A9-2F93FB619CCE Q45898212-2F420FF8-3140-491B-AE80-305CBDA27F14 Q46594306-6924611E-086A-4A93-9C41-EFF5A7C90ACF Q46809828-B160B0B6-5BA8-49AE-AD0A-7C5A9BC57A54 Q47854801-45A757FF-0F7D-498A-A62A-6631D924D9A7 Q48220900-1322819B-D374-420B-B8A5-C2C97F1D5336 Q49227467-9DC96D6A-8B8A-4D37-AF49-0D67FB182018 Q50277873-B4C0941A-1B7E-4B65-B81F-698DB763E4A9 Q52887320-BDCCD3BA-F4FD-4DCD-B747-6441B62E7929 Q53255318-92487AD6-F366-4C67-B0AD-EBAAA68A2525 Q53546061-5588C033-2368-4007-B065-78C0B11E83A7 Q55386497-E78C1177-2684-4B0D-B493-5C73F21D07D0

P2860

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

http://www.wikidata.org/entity/Q34304330

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@ast

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@en

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@nl

type

label

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@ast

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@en

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@nl

prefLabel

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@ast

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@en

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@nl

P1433

Q34304330-DEC49CC4-AC47-44D7-A2C9-CC7CF18FD192

P1476

Q34304330-6DD6E26A-35B6-4990-8ACD-4F74E1BC69B5

P2093

Q34304330-33C1A557-933A-4A44-A026-454083C41B61

Q34304330-9A7EEF2D-946C-40A3-9570-19167056071F

Q34304330-A3D57BF4-A56D-465D-8C18-C614231ABC19

P2860

Q34304330-1134C873-9E5D-4054-8FD9-D5D8FAE226D5

Q34304330-1AFBA9C2-9237-4812-9518-8CF471FA937B

Q34304330-2F1FFA23-713B-47EA-B172-8E575CB3B484

Q34304330-383F6EC9-B24B-44E4-A86D-31C43F1C5E82

Q34304330-3EA009F7-2F32-4F05-815B-8BE58809C6AF

Q34304330-437E4DB4-30FF-473D-97A5-B7855A7407FC

Q34304330-4C4ACB99-FEBE-42B2-9789-A5E5D7E3CDA7

Q34304330-4ECA06EF-A069-4D9D-AE62-2DF0A4B56F28

Q34304330-555466CE-B023-49AD-A432-C7994696B027

Q34304330-60FC44DB-AE2F-4DA8-B4A2-494E6D381446

P304

Q34304330-A730560A-9380-45AD-82A3-2AD84B4C61DB

P31

Q34304330-256DE900-9100-41D8-A252-4AE46268EC26

P356

Q34304330-0CB02E41-7C5E-4E05-97EA-64737C7AFEE3

P433

Q34304330-E0065770-B14F-4CA3-A9EF-185822BDE6BD

P478

Q34304330-4932FEF0-E745-4A96-9D88-51E30B96C115

P577

Q34304330-DFB751E4-7DC3-424C-969A-3F414A30A5B4

P698

Q34304330-FEECB9F5-2263-46D8-B739-BC3B75143FD2

P921

Q34304330-E03032E6-6922-4CF3-860C-245FE3204556

P356

P1433

Drug Testing and Analysis

P1476

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

@en

P2093

Grigory Rodchenkov

http://www.w3.org/2001/XMLSchema#string

Ilya Prasolov

http://www.w3.org/2001/XMLSchema#string

Tim Sobolevsky

http://www.w3.org/2001/XMLSchema#string

P2860

Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity

Chemical analysis of synthetic cannabinoids as designer drugs in herbal products

Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.

Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203.

Detection of JWH-018 metabolites in smoking mixture post-administration urine.

Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary.

Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.

The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry.

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system.

Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS.

P304

745-753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.1418

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23042760

http://www.w3.org/2001/XMLSchema#string

P921